Lumigan, Bimatoprost News

A 72 year-old Caucasian male was referred to the Wills Eye Institute Glaucoma Service for consultation regarding treatment options for glaucoma in both eyes.

Taking a prescription drug for a cosmetic side effect -- at the risk of other side effects -- may seem risky.

Abel Pharmboy is the nom de plume of an academic researcher and educator who took his PhD in Pharmacology and Therapeutics and BS in Toxicology.

In December, the Food and Drug Administration approved Latisse to treat "hypotrichosis," a disease of deficient eyelashes.

Kathleen M. Coyle is an eyelash fanatic. Describing herself as '80s girl' who loves big hair and lots of mascara, she has tried everything from a Jan Marini brand eyelash enhancer from that decade, to a painstakingly slow eyelash extension process in which individual lashes are bonded to the extensions, as with hair extensions.

When glaucoma sufferers started using the eye-drop drug Lumigan eight years ago, who knew there'd be fringe benefits: longer, lusher, darker eyelashes.

A weekly wrap up of green and socially minded business news from the gang at TriplePundit.com Are Trustmarks Badly Designed? - BBMG's Mitch Baranowski weighs in on the design of "Trustmarks" - Energy Star, Recyclable, USDA Organic and so on.

Above, the beautiful Brooke Sheilds. Below, the beautiful Brooke Shields . Aging is such a cruel process.

Rosemary Abendroth sums up the problem in two words: eyelash envy. "I'm a blonde and when you're a blonde you always wish for longer, thicker, blacker lashes," says the PR director from Manhattan.

On September 10, 2009, the FDA sent Allergan a notice that its Latisse Web site was misleading .

One can only hope that what goes around comes around. Lately, it has become common that a drug designed for one purpose gets a second life because of desirable side effects that have little or nothing to do with the original intent.

What's in a look? For women who want longer eyelashes, apparently a lot. That's why a new drug that promises to grow longer, fuller lashes is getting a lot of attention.

NEW YORK A drug made by Irvine, Calif.-based Allergan for treating glaucoma and missing eyelashes may also work as a treatment for hair loss, according to published reports.

Some women are willing to try just about anything to make their skimpy eyelashes look better.

There are few good indications to whether Allergan 's Latisse could also cure male-pattern baldness.

Allergan believes it may have a cure for baldness in the form of Latisse/Lumigan , its glaucoma drug-cum-eyelash enhancer.

Allergan believes it may have a cure for baldness in the form of Latisse/Lumigan , its glaucoma drug-cum-eyelash enhancer.

What's in a look? For women who want longer eyelashes -- apparently a lot. That's why a new drug that promises to grow longer, fuller lashes is getting a lot of attention.

What's in a look? For women who want longer eyelashesa 'apparently a lot. That's why a new drug that promises to grow longer, fuller lashes is getting a lot of attention.

Should these popular drugs be stopped for cataract surgery? And if so, when should they be restarted? Because glaucoma is a chronic con- dition affecting primarily the elderly, many of these patients develop visually significant cataracts under our care.